Cargando…

Long‐Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery Disease

BACKGROUND: The Heart Team (HT) comprises integrated interdisciplinary decision making. Current guidelines assign a Class Ic recommendation for an HT approach to complex coronary artery disease (CAD). However, there remains a paucity of data in regard to hard clinical end points. The aim was to dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Patterson, Tiffany, McConkey, Hannah Z.R., Ahmed‐Jushuf, Fiyyaz, Moschonas, Konstantinos, Nguyen, Hanna, Karamasis, Grigoris V., Perera, Divaka, Clapp, Brian R., Roxburgh, James, Blauth, Christopher, Young, Christopher P., Redwood, Simon R., Pavlidis, Antonis N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507188/
https://www.ncbi.nlm.nih.gov/pubmed/30943827
http://dx.doi.org/10.1161/JAHA.118.011279
_version_ 1783416980114505728
author Patterson, Tiffany
McConkey, Hannah Z.R.
Ahmed‐Jushuf, Fiyyaz
Moschonas, Konstantinos
Nguyen, Hanna
Karamasis, Grigoris V.
Perera, Divaka
Clapp, Brian R.
Roxburgh, James
Blauth, Christopher
Young, Christopher P.
Redwood, Simon R.
Pavlidis, Antonis N.
author_facet Patterson, Tiffany
McConkey, Hannah Z.R.
Ahmed‐Jushuf, Fiyyaz
Moschonas, Konstantinos
Nguyen, Hanna
Karamasis, Grigoris V.
Perera, Divaka
Clapp, Brian R.
Roxburgh, James
Blauth, Christopher
Young, Christopher P.
Redwood, Simon R.
Pavlidis, Antonis N.
author_sort Patterson, Tiffany
collection PubMed
description BACKGROUND: The Heart Team (HT) comprises integrated interdisciplinary decision making. Current guidelines assign a Class Ic recommendation for an HT approach to complex coronary artery disease (CAD). However, there remains a paucity of data in regard to hard clinical end points. The aim was to determine characteristics and outcomes in patients with complex CAD following HT discussion. METHODS AND RESULTS: This observational study was conducted at St Thomas’ Hospital (London, UK). Case mixture included unprotected left main, 2‐vessel (including proximal left anterior descending artery) CAD, 3‐vessel CAD, or anatomical and/or clinical equipoise. HT strategy was defined as optimal medical therapy (OMT) alone, OMT+percutaneous coronary intervention (PCI), or OMT+coronary artery bypass grafting. From April 2012 to 2013, 51 HT meetings were held and 398 cases were discussed. Patients tended to have multivessel CAD (74.1%), high SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) scores (median, 30; interquartile range, 23–39), and average age 69±11 years. Multinomial logistic regression analysis performed to determine variables associated with HT strategy demonstrated decreased likelihood of undergoing PCI compared with OMT in older patients with chronic kidney disease and peripheral vascular disease. The odds of undergoing coronary artery bypass grafting compared with OMT decreased in the presence of cardiogenic shock and left ventricular dysfunction and increased in younger patients with 3‐vessel CAD. Three‐year survival was 60.8% (84 of 137) in the OMT cohort, 84.3% (107 of 127) in the OMT+PCI cohort, and 90.2% in the OMT+coronary artery bypass grafting cohort (92 of 102). CONCLUSIONS: In our experience, the HT approach involved a careful selection process resulting in appropriate patient‐specific decision making and good long‐term outcomes in patients with complex CAD.
format Online
Article
Text
id pubmed-6507188
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65071882019-05-13 Long‐Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery Disease Patterson, Tiffany McConkey, Hannah Z.R. Ahmed‐Jushuf, Fiyyaz Moschonas, Konstantinos Nguyen, Hanna Karamasis, Grigoris V. Perera, Divaka Clapp, Brian R. Roxburgh, James Blauth, Christopher Young, Christopher P. Redwood, Simon R. Pavlidis, Antonis N. J Am Heart Assoc Original Research BACKGROUND: The Heart Team (HT) comprises integrated interdisciplinary decision making. Current guidelines assign a Class Ic recommendation for an HT approach to complex coronary artery disease (CAD). However, there remains a paucity of data in regard to hard clinical end points. The aim was to determine characteristics and outcomes in patients with complex CAD following HT discussion. METHODS AND RESULTS: This observational study was conducted at St Thomas’ Hospital (London, UK). Case mixture included unprotected left main, 2‐vessel (including proximal left anterior descending artery) CAD, 3‐vessel CAD, or anatomical and/or clinical equipoise. HT strategy was defined as optimal medical therapy (OMT) alone, OMT+percutaneous coronary intervention (PCI), or OMT+coronary artery bypass grafting. From April 2012 to 2013, 51 HT meetings were held and 398 cases were discussed. Patients tended to have multivessel CAD (74.1%), high SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) scores (median, 30; interquartile range, 23–39), and average age 69±11 years. Multinomial logistic regression analysis performed to determine variables associated with HT strategy demonstrated decreased likelihood of undergoing PCI compared with OMT in older patients with chronic kidney disease and peripheral vascular disease. The odds of undergoing coronary artery bypass grafting compared with OMT decreased in the presence of cardiogenic shock and left ventricular dysfunction and increased in younger patients with 3‐vessel CAD. Three‐year survival was 60.8% (84 of 137) in the OMT cohort, 84.3% (107 of 127) in the OMT+PCI cohort, and 90.2% in the OMT+coronary artery bypass grafting cohort (92 of 102). CONCLUSIONS: In our experience, the HT approach involved a careful selection process resulting in appropriate patient‐specific decision making and good long‐term outcomes in patients with complex CAD. John Wiley and Sons Inc. 2019-04-04 /pmc/articles/PMC6507188/ /pubmed/30943827 http://dx.doi.org/10.1161/JAHA.118.011279 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Patterson, Tiffany
McConkey, Hannah Z.R.
Ahmed‐Jushuf, Fiyyaz
Moschonas, Konstantinos
Nguyen, Hanna
Karamasis, Grigoris V.
Perera, Divaka
Clapp, Brian R.
Roxburgh, James
Blauth, Christopher
Young, Christopher P.
Redwood, Simon R.
Pavlidis, Antonis N.
Long‐Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery Disease
title Long‐Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery Disease
title_full Long‐Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery Disease
title_fullStr Long‐Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery Disease
title_full_unstemmed Long‐Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery Disease
title_short Long‐Term Outcomes Following Heart Team Revascularization Recommendations in Complex Coronary Artery Disease
title_sort long‐term outcomes following heart team revascularization recommendations in complex coronary artery disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507188/
https://www.ncbi.nlm.nih.gov/pubmed/30943827
http://dx.doi.org/10.1161/JAHA.118.011279
work_keys_str_mv AT pattersontiffany longtermoutcomesfollowingheartteamrevascularizationrecommendationsincomplexcoronaryarterydisease
AT mcconkeyhannahzr longtermoutcomesfollowingheartteamrevascularizationrecommendationsincomplexcoronaryarterydisease
AT ahmedjushuffiyyaz longtermoutcomesfollowingheartteamrevascularizationrecommendationsincomplexcoronaryarterydisease
AT moschonaskonstantinos longtermoutcomesfollowingheartteamrevascularizationrecommendationsincomplexcoronaryarterydisease
AT nguyenhanna longtermoutcomesfollowingheartteamrevascularizationrecommendationsincomplexcoronaryarterydisease
AT karamasisgrigorisv longtermoutcomesfollowingheartteamrevascularizationrecommendationsincomplexcoronaryarterydisease
AT pereradivaka longtermoutcomesfollowingheartteamrevascularizationrecommendationsincomplexcoronaryarterydisease
AT clappbrianr longtermoutcomesfollowingheartteamrevascularizationrecommendationsincomplexcoronaryarterydisease
AT roxburghjames longtermoutcomesfollowingheartteamrevascularizationrecommendationsincomplexcoronaryarterydisease
AT blauthchristopher longtermoutcomesfollowingheartteamrevascularizationrecommendationsincomplexcoronaryarterydisease
AT youngchristopherp longtermoutcomesfollowingheartteamrevascularizationrecommendationsincomplexcoronaryarterydisease
AT redwoodsimonr longtermoutcomesfollowingheartteamrevascularizationrecommendationsincomplexcoronaryarterydisease
AT pavlidisantonisn longtermoutcomesfollowingheartteamrevascularizationrecommendationsincomplexcoronaryarterydisease